Results 51 to 60 of about 11,282 (226)

Primary Malignant Mesothelioma of the Liver: Case Report and Review of the Literature

European Journal of Case Reports in Internal Medicine, 2020
Introduction: Primary malignant mesothelioma of the liver is an extremely rare cancer, with only 16 cases reported in the literature so far. Diagnosis is challenging due to morphological similarity with common liver cancers and the extreme rarity of the ...
Subash Ghimire, Nilisha Regmi, Tsujung Yang, Harshil Shah, Ukorn Srivatana, Ashit Sarker, Hafiz Khan   +6 more
doaj   +1 more source

Animal Models and Treatment of Pulmonary Fibrosis: Pharmacogenetic and Nonpharmacogenetic

International Journal of Clinical Practice, Volume 2026, Issue 1, 2026.
Pulmonary fibrosis is a significant lung injury caused by multiple factors that profoundly affect the human quality of life. Currently, various animal models are used to understand the aetiology of pulmonary fibrosis and develop treatments. However, only pharmacogenetic models of pulmonary fibrosis have been discussed, and there have been no reviews of
Xingyu Fang, Haonan Bai, Zhanhong Cao, Dianyu Li, Yu An, Xiaohui Zhao, Nan Chen, Suraiya Saleem   +7 more
wiley   +1 more source

Evaluation of manganese superoxide dismutase and thioredoxin2 levels in asbestos-induced pleural mesothelioma

Medicine Science, 2020
Asbestos is a mineral known as human carcinogenic material. Exposure to asbestos both in an occupational and environmental way causes asbestosis and mesothelioma.
Abdullah Sivrikaya, Bayram Metin, Esma Menevse, Yavuz Selim Intepe, Ayse Yesim Gocmen   +4 more
doaj   +1 more source

The association between polypharmacy and mortality in patients with heart failure: Results from the PULSE dataset

ESC Heart Failure, Volume 12, Issue 6, Page 4316-4325, December 2025.
A study of 660 heart failure patients (mean age 76.1) found that polypharmacy was common, with only 5% discharged without it, and 60% had died by the end of a median 2.9‐year follow‐up. In patients with heart failure with reduced ejection fraction (HFrEF), hyperpolypharmacy was associated with significantly higher mortality, while in those with ...
Janine Beezer, Andrew L. Clark, Adam Todd, Andrew Kingston, Andrew Husband   +4 more
wiley   +1 more source

Microplastics in Human Bronchoalveolar Lavage Fluid

Respirology, Volume 30, Issue 12, Page 1141-1152, December 2025.
We established a microplastic detection method using bronchoalveolar lavage fluid. The method detected microplastics, particularly those under 10 μm, in all patients, linked to lung and systemic inflammation. The potential relationship between microplastics and lung and systemic inflammation provides a foundation for larger studies on their health ...
Takatomo Tokito, Takashi Kido, Osamu Nagafuchi, Koichi Tomoshige, Koyomi Nakazawa, Ken'ichi Shinozuka, Shuntaro Sato, Kumiko Kido, Yasuko Noguchi, Takamune Matsumoto, Satoshi Mizoguchi, Ritsuko Murakami, Hirokazu Yura, Hiroshi Ishimoto, Takahiro Takazono, Noriho Sakamoto, Yuji Ishimatsu, Yoshimasa Tanaka, Keitaro Matsumoto, Takeshi Nagayasu, Hiroshi Mukae   +20 more
wiley   +1 more source

Mortality and Cancer Incidence After Exposure to Blue Asbestos in Childhood: A Further 10 Years of Follow‐Up

American Journal of Industrial Medicine, Volume 68, Issue 9, Page 772-783, September 2025.
ABSTRACT Objectives The impact of early‐life exposure to asbestos on disease risk remains uncertain. Childhood exposure to blue asbestos at Wittenoom has previously been linked to the development of malignant mesothelioma and various cancers in adulthood, as well as to a greater risk of all‐cause mortality compared with the general population.
Renee N. Carey, Alison Reid, Nicholas de Klerk, Peter Cinquini, Nola Olsen, Fraser Brims, Peter Franklin   +6 more
wiley   +1 more source

Comments on the 2014 Helsinki Consensus Report on Asbestos

Annals of Global Health, 2016
Background: The Finnish Institute of Occupational Health (FIOH) convened an Expert Committee in 2014 to update the 1997 and 2000 Helsinki criteria on asbestos, asbestosis, and cancer.
Philip J. Landrigan, Collegium Ramazzini
doaj   +1 more source

Ferroptosis in Pneumoconiosis: From Molecular and Cellular Mechanisms to Therapeutic Strategies

Med Research, Volume 1, Issue 2, Page 239-256, September 2025.
Targeting lung various cells to alleviate pneumoconiosis by suppressing ferroptosis. AAV9‐HGF, adeno‐associated virus‐hepatocyte growth factor; DFP, deferiprone; DHQ, dihydroquercetin; Fer‐1, ferrostatin‐1; IL‐1β, interleukin‐1β; NMN, nicotinamide mononucleotide; sh‐SLC39A14, shRNA targeting solute carrier family 39 member 14; si‐OC‐STAMP, siRNA ...
Mengli Yan, Jing Zhang, Gaili Ji, Xiaobin Fang, Chunheng Mo   +4 more
wiley   +1 more source

Occupational diseases in Poland — An overview of current trends

International Journal of Occupational Medicine and Environmental Health, 2013
Introduction: The number of occupational diseases (OD) recorded in Poland in the 1990's rapidly increased, and the numer of recognized cases has steadily decreased until now.
Neonila Szeszenia-Dąbrowska, Urszula Wilczyńska   +1 more
doaj   +1 more source

Thermally treated granite slurry waste as a mitigating agent for sisal fiber mineralization in fiber‐cement composites

International Journal of Applied Ceramic Technology, Volume 22, Issue 5, September/October 2025.
Abstract This study explores the use of thermally treated granite slurry waste to mitigate the mineralization of sisal fibers in fiber‐cement composites. Granite waste was thermally treated at 600°C and 900°C, and the treated materials were analyzed using X‐ray fluorescence (XRF), Fourier transform infrared spectroscopy (FTIR), and thermogravimetric ...
Maximo A. U. Gutiérrez, Thamires A. da Silveira, Felipe V. Ribeiro, Arthur B. Aramburu, Cristian C. Gomes, Margarete R. F. Gonçalves, Rafael A. Delucis   +6 more
wiley   +1 more source